TORONTO, April 09, 2018 -- Fulcrum Capital Partners (Fulcrum) is pleased to announce an investment in Accucam Machining (Accucam).
|
|||||
Based in Cambridge, Canada, Accucam Machining is a leading supplier of steel parts to heavy equipment OEMs in material handling, agricultural and construction industries around the world. Accucam provides design and engineering, machining, casting, assemblies, paint and warehousing services through facilities in Cambridge, Canada and Qingdao, China.
Fulcrum has partnered with Accucam’s founders to support further growth initiatives. The investment was made by Fulcrum Capital's Private Equity Fund V. Accucam marks the seventh platform investment made from Fund V, which closed in July 2015.
About Fulcrum Capital Partners
Fulcrum Capital Partners is an independent private equity firm focused on the Canadian middle market. Fulcrum has invested more than $750 million over the past two decades and is currently investing from its fifth private equity fund with $350 million in committed capital.
Fulcrum has helped build and grow more than 45 platform companies by providing strategic, operational, financial and M&A expertise. Fulcrum maintains a national presence with multiple offices across Canada. Visit our website to learn more.
For more information, please contact: Fulcrum Capital Partners Phone: 416.864.2761 E-mail: [email protected]


Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 



